Pharma giants pressed by Senate Democrats over Trump pricing deals

Senate Democrats are intensifying their scrutiny of major pharmaceutical companies, demanding greater transparency and accountability regarding drug pricing agreements made during the Trump administration. The lawmakers are seeking to understand the full impact of these deals on prescription drug costs for American consumers and to ensure that any benefits are being passed on to patients.